Contemporary NSTEMI management: the role of the hospitalist [PDF]
Non-ST-segment elevation myocardial infarction (NSTEMI) is defined as elevated cardiac biomarkers of necrosis in the absence of persistent ST-segment elevation in the setting of anginal symptoms or other acute event. It carries a poorer prognosis than most ST-segment elevation events, owing to the typical comorbidity burden of the older NSTEMI patients
, Tracy Wang
exaly +3 more sources
Managing NSTEMI in older patients [PDF]
Alberto Cordero +1 more
exaly +7 more sources
The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial [PDF]
Background: Given the potential anti-ischemic effects of allopurinol, we aimed to assess whether allopurinol administration may reduce myocardial injury following non-ST elevation myocardial infarction (NSTEMI). Methods: A randomized clinical trial (RCT)
Sajad Khiali +5 more
doaj +1 more source
Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI) [PDF]
Background: Coronary ischemia can lead to myocardial damage and necrosis. The pathogenesis of cardiovascular diseases often includes increased oxidative stress and decreased antioxidant defense.
Aladağ Nesim +6 more
doaj +1 more source
Acute myocardial infarction at a district hospital in KwaZulu-Natal – Management and outcomes
Background: Acute myocardial infarction (AMI) following ischaemic heart disease (IHD) is associated with increased morbidity and mortality. The condition remains a management challenge in resource-constrained environments.
Zakariya Badat, Selvandran Rangiah
doaj +1 more source
Complete Revascularization in NSTEMI and MVD: What Does "Complete" Mean in Real-World Practice? [PDF]
Kuramitsu S.
europepmc +2 more sources
Background The detailed causes of death in non–ST-segment–elevation myocardial infarction (NSTEMI) have not been adequately evaluated compared to those in ST-segment elevation myocardial infarction (STEMI).
Yasuaki Takeji +27 more
doaj +2 more sources
Management of Acute Coronary Syndrome in the COVID Era
Management of acute coronary syndrome (ACS) has emerged as a challenge during the COVID-19 era. There has been a significant increase in the morbidity and mortality associated with ACS both as a direct and an indirect consequence of the pandemic. In this
Ronak Bahuva, Joe Aoun, Sachin S. Goel
doaj +1 more source
Vascular senescence and atherosclerotic plaque vulnerability: investigating the telomere-mitochondria crosstalk—rationale and design of the VICTORIA Study [PDF]
Vascular aging is recognized as one of the hallmarks of atherosclerosis. Currently, a growing body of evidence suggests that there exists a mutual crosstalk between telomere dysfunction and mitochondrial dysmetabolism during the process of vascular ...
Jonica Campolo +11 more
doaj +1 more source
Background To analyze incidence, use of therapeutic procedures, and in-hospital outcomes in patients with ST elevation myocardial infarction (STEMI) and non-ST elevation myocardial infarction (NSTEMI) according to the presence of type 2 diabetes (T2DM ...
Ana Lopez-de-Andres +9 more
doaj +1 more source

